Neutraceuticals | Role Of Neutraceuticals in Diabetes, Cancer | Herb Interaction | HDT 6th Semester
This is a comprehensive lecture on Unit 2 of Herbal Drug Technology covering nutraceuticals, their role in various diseases (diabetes, cancer, cardiovascular diseases, IBS), and herb-drug interactions. The instructor provides detailed coverage of nutraceuticals' definition, market growth, classification, and therapeutic applications in managing chronic conditions.
Summary
The lecture begins with an introduction to nutraceuticals, defined as food or food components that provide pharmacological benefits including disease prevention and treatment. The term was coined by Stephen DeFilis in 1989, combining 'nutrition' and 'pharmaceuticals.' The global nutraceuticals market shows strong growth from $455 billion in 2024 to a projected $754 billion by 2029, driven by rising health awareness, lifestyle diseases, and preference for natural products. The classification covers three bases: availability (functional foods, beverages, dietary supplements), source (plant, animal, microbial), and therapeutic use (antioxidant, anti-inflammatory, bone protective, antibacterial). The instructor extensively covers the role of nutraceuticals in diabetes management, explaining how dietary fibers, antioxidants, chromium, polyphenols, and alpha-lipoic acid help control blood glucose levels. Cancer applications focus on antioxidants, polyphenols, carotenoids, and curcumin for prevention and supportive care. Cardiovascular benefits include omega-3 fatty acids, dietary fibers, and plant sterols for cholesterol management. For IBS and gastrointestinal disorders, probiotics, prebiotics, and fiber supplements provide relief. The lecture then details various herbs including alfalfa, chicory, ginger, fenugreek, garlic, honey, amla, ginseng, ashwagandha, and spirulina, covering their biological sources, morphology, chemical constituents, and health benefits. Finally, herb-drug interactions are discussed, focusing on hypericum, kava-kava, ginkgo biloba, ginseng, garlic, black pepper, and ephedra, detailing their potential interactions with pharmaceutical drugs and associated risks.
Key Insights
- The instructor explains that nutraceuticals are defined as food or parts of food that provide pharmacological benefits including prevention and treatment of disease, with the term coined by Stephen DeFilis in 1989
- The global nutraceuticals market shows impressive growth from $455 billion in 2024 to projected $754 billion by 2029, with a CAGR of 8.4-10.9%
- India is becoming a major market for nutraceuticals due to its strong base in Ayurveda and herbal medicines, with people increasingly preferring herbal products over chemicals
- The instructor emphasizes that India has become the diabetes capital with 1/4 of the world's diabetic patients, making diabetes management through nutraceuticals particularly relevant
- Dietary fibers work by slowing gastric emptying, which helps reduce post-prandial blood glucose spikes in diabetic patients
- Chia seeds are highlighted as an excellent source of soluble fiber for diabetes management, recommending soaking them overnight and consuming with lemon and black salt in the morning
- The instructor explains that nutraceuticals cannot cure cancer but can provide supportive care during chemotherapy by reducing oxidative stress and inflammation
- Green tea contains EGCG (epigallocatechin gallate) which is well-known as an anti-cancer compound with significant therapeutic potential
- For cardiovascular health, omega-3 fatty acids prevent platelet aggregation and are considered highly beneficial for heart health
- The instructor reveals personal experience with IBS, explaining it as a mind-gut connection disorder where mental state directly affects digestive health
- Hypericum (St. John's Wort) is identified as a strong liver enzyme inducer that can significantly alter the metabolism and elimination of other drugs
- Ginkgo biloba has antiplatelet and vasodilatory activity, which can increase bleeding risk when combined with anticoagulant medications
- Black pepper contains piperine which inhibits drug metabolizing enzymes, leading to increased bioavailability and potential toxicity of drugs with narrow therapeutic index
- The instructor emphasizes that drug interactions are not always harmful, citing the example of turmeric with black pepper enhancing curcumin absorption as a beneficial interaction
- Ephedra acts as a sympathomimetic stimulant that can cause hypertensive crisis when combined with MAO inhibitors and antidepressants
Topics
Full transcript available for MurmurCast members
Sign Up to Access